Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Belite Bio, Inc. ADR (BLTE)
NASDAQ:BLTE
RESEARCH TOOLSreports
Belite Bio, Inc. ADR (BLTE) Stock Price & Analysis
17 Followers
BLTE Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$11.00 - $48.60
Previous Close$36.6
Volume32.83K
Average Volume (3M)57.02K
Market Cap
N/A
Enterprise ValueN/A
Total Cash (Recent Filing)$88.16M
Total Debt (Recent Filing)$886.00K
Price to Earnings (P/E)-29.5
Beta-0.45
Next Earnings
May 08, 2024EPS Estimate
-$0.29Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-1.24
Shares Outstanding29,149,444
10 Day Avg. Volume26,730
30 Day Avg. Volume57,015
Standard Deviation0.31
R-Squared0.08
Alpha0.11
Financial Highlights & Ratios
Price to Book (P/B)11.89
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
$56.50Price Target Upside57.47% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering4
Belite Bio, Inc. ADR News
Ownership Overview
0.00%
Insiders
0.03% Mutual Funds
0.20% Other Institutional Investors
99.77% Public Companies and
Individual Investors
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
BLTE FAQ
What was Belite Bio, Inc. ADR’s price range in the past 12 months?
Belite Bio, Inc. ADR lowest stock price was $11.00 and its highest was $48.60 in the past 12 months.
What is Belite Bio, Inc. ADR’s market cap?
Currently, no data Available
When is Belite Bio, Inc. ADR’s upcoming earnings report date?
Belite Bio, Inc. ADR’s upcoming earnings report date is May 08, 2024 which is in 19 days.
How were Belite Bio, Inc. ADR’s earnings last quarter?
Belite Bio, Inc. ADR released its earnings results on Mar 12, 2024. The company reported -$0.25 earnings per share for the quarter, beating the consensus estimate of -$0.3 by $0.05.
Is Belite Bio, Inc. ADR overvalued?
According to Wall Street analysts Belite Bio, Inc. ADR’s price is currently Undervalued.
Does Belite Bio, Inc. ADR pay dividends?
Belite Bio, Inc. ADR does not currently pay dividends.
What is Belite Bio, Inc. ADR’s EPS estimate?
Belite Bio, Inc. ADR’s EPS estimate is -$0.29.
How many shares outstanding does Belite Bio, Inc. ADR have?
Belite Bio, Inc. ADR has 29,149,445 shares outstanding.
What happened to Belite Bio, Inc. ADR’s price movement after its last earnings report?
Belite Bio, Inc. ADR reported an EPS of -$0.25 in its last earnings report, beating expectations of -$0.3. Following the earnings report the stock price went down -12.466%.
Which hedge fund is a major shareholder of Belite Bio, Inc. ADR?
Among the largest hedge funds holding Belite Bio, Inc. ADR’s share is EntryPoint Capital, LLC. It holds Belite Bio, Inc. ADR’s shares valued at 36K.
---
Belite Bio, Inc. ADR Stock Smart Score
Company Description
Belite Bio, Inc. ADR
Belite Bio Inc is a clinical-stage biopharmaceutical drug development company focused on novel therapeutics targeting untreatable eye diseases involving retinal degeneration such as atrophic age-related macular degeneration and autosomal recessive Stargardt disease or STGD1, both of which progressively lead to permanent blindness, and metabolic diseases such as non-alcoholic fatty liver disease, or NAFLD, nonalcoholic steatohepatitis, or NASH, type 2 diabetes, or T2D, and gout.
---
BLTE Stock 12 Months Forecast
Average Price Target
$56.50
▲(57.47% Upside)
Technical Analysis
Best Analysts Covering BLTE
1 Year
1 Year Success Rate
7/11 ratings generated profit
1 Year Average Return
+24.91%
reiterated a buy rating 28 days ago
Copying Yi Chen's trades and holding each position for 1 Year would result in 63.64% of your transactions generating a profit, with an average return of +24.91% per trade.
---